World's Best Scientists 2026 revealed!
Bulletin du Cancer
H-index 14

Bulletin du Cancer

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 1888 89 165 13

Additional Metrics

Number of Best Scientists*: 133
Documents by Best Scientists*: 218
Top 100 Ranked Scientists*: 0
SCIMAGO H-index: 44
SCIMAGO SJR: 0.327
Impact Factor: N/A

Overview

Top Research Topics at Bulletin Du Cancer?

The scientific interests tackled in the journal are Internal medicine, Cancer, Gynecology, Oncology and Surgery. While work presented in the journal provided substantial information on Internal medicine, it also covered topics in Gastroenterology and Endocrinology. The work on Cancer addressed in it expands to the thematically related Cancer research.

It focuses on Oncology but the discussions also offer insight into other areas such as Clinical trial and Disease.

  • Internal medicine (18.61%)
  • Cancer (14.32%)
  • Gynecology (13.45%)

What are the most cited papers published in the journal?

  • [Esophageal cancer in Ille-et-Vilaine in relation to levels of alcohol and tobacco consumption. Risks are multiplying]. (191 citations)
  • Epidermodysplasia verruciformis. An autosomal recessive disease characterized by viral warts and skin cancer. A model for viral oncogenesis. (164 citations)
  • [Sem: a suitable statistical software adaptated for research in oncology] (154 citations)

Research areas of the most cited articles at Bulletin Du Cancer:

The most cited papers are mainly concerned with subjects like Cancer, Internal medicine, Surgery, Gynecology and Cancer research. The journal articles focus on Cancer but the discussions also offer insight into other areas such as Epidemiology, Incidence (epidemiology) and Pathology. The most cited publications deal with Internal medicine in conjunction with Oncology and similar fields in Clinical trial and Disease.

What topics the last edition of the journal is best known for?

  • Cancer
  • Internal medicine
  • Disease

The previous edition focused in particular on these issues:

Bulletin Du Cancer focuses largely on the fields of Internal medicine, Oncology, Cancer, Gynecology and Cancer research. It connects research in Internal medicine with the related topic of Gastroenterology. The Oncology works featured in Bulletin Du Cancer incorporate elements from Immunotherapy, Drug approval, First line and Lymphoma.

Cancer research presented is mostly focused on the subject of Breast cancer. Topics in Cancer research were tackled in line with various other fields like Lung cancer and Prostate cancer. MEDLINE and Neoplasms therapy are some topics wherein Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) research discussed in it have an impact.

The most cited articles from the last journal are:

  • An overview of autophagy: Mechanism, regulation and research progress. (9 citations)
  • Management of sarcomas in children, adolescents and adults: Interactions in two different age groups under the umbrellas of GSF-GETO and SFCE, with the support of the NETSARC+ network. (4 citations)
  • Vaccination contre le virus de l’hépatite B et prévention du cancer du foie (3 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Bulletin Du Cancer (based on the number of publications) are:

  • Jacques-Olivier Bay (124 papers) published 9 papers at the last edition, 1 less than at the previous edition,
  • Ibrahim Yakoub-Agha (90 papers) published 13 papers at the last edition, 15 less than at the previous edition,
  • Stéphane Vignot (81 papers) absent at the last edition,
  • Christian-Jacques Larsen (73 papers) absent at the last edition,
  • Jean-Yves Blay (71 papers) published 3 papers at the last edition, 2 more than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Bulletin Du Cancer (based on the number of publications) are:

  • Institut Gustave Roussy (667 papers) published 17 papers at the last edition, 1 less than at the previous edition,
  • French Institute of Health and Medical Research (466 papers) published 15 papers at the last edition, 21 less than at the previous edition,
  • Curie Institute (384 papers) published 31 papers at the last edition, 9 more than at the previous edition,
  • University of Paris (191 papers) published 31 papers at the last edition, 6 less than at the previous edition,
  • Centre national de la recherche scientifique (139 papers) published 2 papers at the last edition, 1 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 25.27% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 64.71% were posted by at least one author from the top 10 institutions publishing in the journal. Another 15.44% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 5.88% of all publications and 13.97% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Application in Practical Medical Practice

An additional dimension of analysis we could consider is its practical application in the medical field, especially in specialties outside of its primary field of oncology, like licensed practical nursing (LPN). This is essential as there is an increasing push towards a more integrated and holistic approach in healthcare, where knowledge from diverse fields are interconnected. For instance, understanding oncology research has practical significance for LPN specialists working with cancer patients. Reading and understanding research on current cancer treatments or preventive strategies can potentially help them provide better patient care. For example, those undertaking lpn programs in Kentucky could gain valuable insights from the Bulletin Du Cancer, as its topics such as cancer research and internal medicine are directly related to their field. Integrating this knowledge into their curriculum could lead to a comprehensive learning experience, preparing them to handle various medical scenarios effectively. The application of Bulletin Du Cancer's research goes beyond academic purpose, furthering the importance of multidisciplinary understanding in healthcare. By emphasizing this, we aim to enhance the significance of this research in practical medical scenarios, as well as its potential to contribute to various medical fields, including nursing.

Top Publications

  • BIONIKK: A phase 2 biomarker driven trial with nivolumab and ipilimumab or VEGFR tyrosine kinase inhibitor (TKI) in naïve metastatic kidney cancer

    Nicolas Epaillard;Audrey Simonaggio;Reza Elaidi;Fouzia Azzouz

    (2020)
    37 Citations
  • [Impact of nutrition on breast cancer mortality and risk of recurrence, a review of the evidence].

    (2020)
    37 Citations
  • [COVID-19 and people followed for breast cancer: French guidelines for clinical practice of Nice-St Paul de Vence, in collaboration with the College Nationale des Gynecologues et Obstetriciens Francais (CNGOF), the Societe d'Imagerie de la FEMme (SIFEM), the Societe Francaise de Chirurgie Oncologique (SFCO), the Societe Francaise de Senologie et Pathologie Mammaire (SFSPM) and the French Breast Cancer Intergroup-UNICANCER (UCBG)]

    Joseph Gligorov;Thomas Bachelot;Jean Yves Pierga;Eric Charles Antoine

    (2020)
    34 Citations
  • COVID-19 and acute lymphoblastic leukemias of children and adolescents: First recommendations of the Leukemia committee of the French Society for the fight against Cancers and Leukemias in children and adolescents (SFCE).

    Jérémie Rouger-Gaudichon;Yves Bertrand;Nicolas Boissel;Benoit Brethon

    (2020)
    25 Citations
  • [SARS-CoV-2/COVID 19 Infection and Solid Cancers: Synthesis of Recommendations for Health Professionals]

    Thomas Grellety;Alain Ravaud;Anne Canivet;Gérard Ganem

    (2020)
    20 Citations
  • Occurrence and number of immune-related adverse events are independently associated with survival in advanced non-small-cell lung cancer treated by nivolumab.

    Linda Bouhlel;Jérôme Doyen;Emmanuel Chamorey;Michel Poudenx

    (2020)
    16 Citations
  • Patients atteints d’un cancer gastrique localisé MSI/dMMR, pas de chimiothérapie mais une immunothérapie périopératoire : l’essai de phase II GERCOR NEONIPIGA vient d’être ouvert au recrutement

    Romain Cohen;Thomas Pudlarz;Marie-Line Garcia-Larnicol;Dewi Vernerey

    (2020)
    16 Citations
  • Vaccination contre le virus de l’hépatite B et prévention du cancer du foie

    Fanny Lebossé;Fabien Zoulim

    (2021)
    16 Citations
  • COVID19 and acute lymphoblastic leukemias of children and adolescents: Updated recommendations (Version 2) of the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE)

    (2021)
    15 Citations
  • Detailed overview on rare malignant ovarian tumors

    Stefanie Aust;Lauriane Eberst;Olivier Tredan;Christine Rousset-Jablonski

    (2020)
    14 Citations

Related Online Degrees & Career Pathways

For those interested in the medical field but looking to diversify their skills, several online degree options provide flexible pathways. An advanced degree like a healthcare mba cost stands out as an affordable way to combine medical knowledge with business acumen, ideal for leadership roles in healthcare organizations.

Nurses seeking to advance their qualifications can explore accelerated programs designed for students without prior nursing backgrounds. The non nursing degree to bsn online pathway offers a fast-tracked opportunity to enter nursing and build foundational skills swiftly.

After securing a BSN, many graduates consider becoming nurse practitioners. Understanding how long to become a nurse practitioner is crucial for planning career progression, as accelerated programs can shorten this timeline to meet growing healthcare demands.

Specializing further, such as becoming a psychiatric nurse practitioner, can be lucrative. Salary variations exist by location, so reviewing psychiatric nurse practitioner salary by state helps prospective students evaluate financial prospects alongside personal preferences.

Best Scientists Contributing to This Journal